- Home
- Industry Reports
- Biotechnology
- Healthcare
- New Born Screening Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Newborn screening is a health program for screening new born’s right after birth to identify problems that affect child’s health in future. Newborn screening contains series of test which helps to detect the diseases and diagnosis are preventing disability and deaths.
Newborn Screening Market share:
Young Screening market is segmented by test type, product, technology, and geography. On basics of test type, the most substantial percentage is in North America because of the effort to reduce the disabilities of children, and genetic disorders for long-term.
Newborn Screening Market size:
Newborn Screening Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of X% to reach USD XX billion by 2024.
North America has the highest market for newborn screening market because of the developed infrastructure; the effort made to reduce disabilities; reimbursement policies are raising the demand for the market. During the forecast period, Asia-Pacific is going to have the quick growth in the market.
Newborn Screening Market growth:
The market for newborn screening is driven by factors such as an increase in some newborn diseases, technological development in healthcare, and incidences of critical congenital heart defects in newborns increasing the growth of newborn screening market.
Newborn Screening Market Industrial Analysis:
Newborn Screening Market is segmented by test type, product, technology, and geography. In this categorisation, the growth of the market is driven by test type segment classified by hearing screening test, dry blood spot test, and critical congenital heart disease test is the fastest growing market in the developed and developing countries.
Newborn Screening Market Outlook:
Newborn Screening is primarily used on infants right after their birth to detect the congenital disorders, which turns into mental retardation, dysfunctioning of organs, for instance, in healthcare and growing critical congenital heart defects have further increased the demand for newborn screening and its predominant in North America especially the US.
Newborn Screening Market Trends:
Agilent Technologies Inc. has acquired Oxfordshire, U.K.-based Cobalt Light Systems in July 2017.
PerkinElmer, Inc. agreed to acquire Euroimmun Medical Laboratory Diagnostics AG., in June 2017.
Newborn Screening Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as:
- PerkinElmer Inc.
- Trivitron Healthcare
- Masimo Corporation
- AB Sciex LLC
- Neogen Labs Pvt. Ltd.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Test Type
6.1 Hearing Screening Test
6.2 Dry Blood Spot Test
6.3 Critical Congenital Heart Disease (CCHD) Test
Chapter 7 Market Segmentation by Product
7.1 Hearing screening devices and Accessories
7.2 Reagents and assay kits
7.3 Newborn disorder Screening Instruments
7.4 Pulse Oximetry
Chapter 8 Market Segmentation by Technology
8.1 DNA based assay
8.2 Electrophoresis
8.3 Hearing Screen Technology
8.4 Enzymes and Immunoassays
8.5 Tandem Mass Spectrometry
8.6 Pulse Oximetry Technology
Chapter 9 Market Segmentation by Geography
9.1 North America
9.1.1 Introduction
9.1.2 United States
9.1.3 Canada
9.1.4 Mexico
9.1.5 Others
9.2 Europe
9.2.1 Introduction
9.2.2 Spain
9.2.3 UK
9.2.4 France
9.2.5 Russia
9.2.6 Italy
9.2.7 Others
9.3 Asia Pacific
9.3.1 Introduction
9.3.2 China
9.3.3 India
9.3.4 Japan
9.3.5 Australia & New Zealand
9.3.6 Others
9.4 The Middle East and Africa
9.4.1 Introduction
9.4.2 South Africa
9.4.3 Middle East Countries
9.4.4 Others
9.5 South America
9.5.1 Introduction
9.5.2 Argentina
9.5.3 Brazil
9.5.5 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Covidien PLC
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 PerkinElmer Inc.
11.3 Trivitron Healthcare
11.4 Masimo Corporation
11.5 AB Sciex LLC
11.6 Neogen Labs Pvt. Ltd.
11.7 Zen Tech S.A.
11.8 Natus Medical
11.9 Agilent Technologies
11.10 GE Healthcare
11.11 Cardinal Health, Inc.
11.12 Bio-Rad Laboratories
11.13 Medtronic Plc
11.14 Thermo Fisher Scientific, Inc.
11.15 Waters Corporation
Chapter 12 Market Estimates and Forecasting
12.1 Market Estimates and Forecasting 2018-2024(USD Million)
12.1.1 Market Estimation and Forecasting by Test Type 2018-2024 (USD Million)
12.1.2 Market Estimates and Forecasting by Product 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecasting by Technology 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,520.07 - €7,560.20
- INR: ₹225,090.13 - ₹675,270.40
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,158.26 - £6,474.78
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Newborn screening is a health program for screening new born’s right after birth to identify problems that affect child’s health in future. Newborn screening contains series of test which helps to detect the diseases and diagnosis are preventing disability and deaths.
Newborn Screening Market share:
Young Screening market is segmented by test type, product, technology, and geography. On basics of test type, the most substantial percentage is in North America because of the effort to reduce the disabilities of children, and genetic disorders for long-term.
Newborn Screening Market size:
Newborn Screening Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of X% to reach USD XX billion by 2024.
North America has the highest market for newborn screening market because of the developed infrastructure; the effort made to reduce disabilities; reimbursement policies are raising the demand for the market. During the forecast period, Asia-Pacific is going to have the quick growth in the market.
Newborn Screening Market growth:
The market for newborn screening is driven by factors such as an increase in some newborn diseases, technological development in healthcare, and incidences of critical congenital heart defects in newborns increasing the growth of newborn screening market.
Newborn Screening Market Industrial Analysis:
Newborn Screening Market is segmented by test type, product, technology, and geography. In this categorisation, the growth of the market is driven by test type segment classified by hearing screening test, dry blood spot test, and critical congenital heart disease test is the fastest growing market in the developed and developing countries.
Newborn Screening Market Outlook:
Newborn Screening is primarily used on infants right after their birth to detect the congenital disorders, which turns into mental retardation, dysfunctioning of organs, for instance, in healthcare and growing critical congenital heart defects have further increased the demand for newborn screening and its predominant in North America especially the US.
Newborn Screening Market Trends:
Agilent Technologies Inc. has acquired Oxfordshire, U.K.-based Cobalt Light Systems in July 2017.
PerkinElmer, Inc. agreed to acquire Euroimmun Medical Laboratory Diagnostics AG., in June 2017.
Newborn Screening Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as:
- PerkinElmer Inc.
- Trivitron Healthcare
- Masimo Corporation
- AB Sciex LLC
- Neogen Labs Pvt. Ltd.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Test Type
6.1 Hearing Screening Test
6.2 Dry Blood Spot Test
6.3 Critical Congenital Heart Disease (CCHD) Test
Chapter 7 Market Segmentation by Product
7.1 Hearing screening devices and Accessories
7.2 Reagents and assay kits
7.3 Newborn disorder Screening Instruments
7.4 Pulse Oximetry
Chapter 8 Market Segmentation by Technology
8.1 DNA based assay
8.2 Electrophoresis
8.3 Hearing Screen Technology
8.4 Enzymes and Immunoassays
8.5 Tandem Mass Spectrometry
8.6 Pulse Oximetry Technology
Chapter 9 Market Segmentation by Geography
9.1 North America
9.1.1 Introduction
9.1.2 United States
9.1.3 Canada
9.1.4 Mexico
9.1.5 Others
9.2 Europe
9.2.1 Introduction
9.2.2 Spain
9.2.3 UK
9.2.4 France
9.2.5 Russia
9.2.6 Italy
9.2.7 Others
9.3 Asia Pacific
9.3.1 Introduction
9.3.2 China
9.3.3 India
9.3.4 Japan
9.3.5 Australia & New Zealand
9.3.6 Others
9.4 The Middle East and Africa
9.4.1 Introduction
9.4.2 South Africa
9.4.3 Middle East Countries
9.4.4 Others
9.5 South America
9.5.1 Introduction
9.5.2 Argentina
9.5.3 Brazil
9.5.5 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Covidien PLC
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 PerkinElmer Inc.
11.3 Trivitron Healthcare
11.4 Masimo Corporation
11.5 AB Sciex LLC
11.6 Neogen Labs Pvt. Ltd.
11.7 Zen Tech S.A.
11.8 Natus Medical
11.9 Agilent Technologies
11.10 GE Healthcare
11.11 Cardinal Health, Inc.
11.12 Bio-Rad Laboratories
11.13 Medtronic Plc
11.14 Thermo Fisher Scientific, Inc.
11.15 Waters Corporation
Chapter 12 Market Estimates and Forecasting
12.1 Market Estimates and Forecasting 2018-2024(USD Million)
12.1.1 Market Estimation and Forecasting by Test Type 2018-2024 (USD Million)
12.1.2 Market Estimates and Forecasting by Product 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecasting by Technology 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.